The American Diabetes Association (ADA) Risk Test, often used for decisions to blood glucose screen or not, lacks studies reporting the reliability or validity for the Spanish version of the tool. The objective of this study is to further validate the utility of the Spanish version of the ADA's Risk Test for Latino Populations. A convenience sample of 316 Latinos participated in this study. A positive but weak statistical correlation was found between blood glucose and the Risk Test score (.138), suggesting low reliability and validity of the Spanish version of the instrument. Two internal consistency estimates of reliability techniques were computed for the Risk Test for diabetes scale items, indicating low reliability.
American Diabetes Association. (2002). The prevention or delay of type 2 diabetes. Diabetes Care, 25, 742-749.
2.
American Diabetes Association. (2004a). Finding the undiagnosed. Volunteer Voice, pp. 1-5.
3.
American Diabetes Association. (2004b). Screening for type 2 diabetes. Diabetes Care, 27, S11-S14.
4.
American Diabetes Association. (2005). Standards for medical care in diabetes. Diabetes Care, 28, S4-S63.
5.
Benjamin, S. M., Valdez, R., Geiss, L. S., Rolka, D. B., & Venkat-Narayan, K. M. (2003). Estimated number of adults with prediabetes in the U.S. in 2000: Opportunities for prevention. Diabetes Care, 26, 645-649.
6.
Briscoe, V. J., & Pichert, J. W. (1999). Evaluation of a program to promote diabetes care via existing agencies in African American communities. ABNF Journal, 10, 111-115.
7.
Centers for Disease Control and Prevention. (2003). Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999-2000. Morbidity and Mortality Weekly Report, 52, 833-837.
8.
Centers for Disease Control and Prevention. (2004). National diabetes fact sheet: General information and national estimate of diabetes in the United States(Rev. ed.). Atlanta, GA: Author.
9.
Green, S. B., & Salkind, N. J. (2005). Using SPSS for Windows and Macintosh: Analyzing and understanding data(4th ed.). Upper Saddle River, NJ: Pearson/Prentice Hall.
10.
Griffin, S. J., Little, P. S., Hales, C. N., Kinmonth, A. L.,& Wareham, N. J. (2000). Diabetes risk score: Towards earlier detection of type 2 diabetes in general practice. Diabetes Metabolic Research, 16, 164-171.
11.
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., et al. (1998). Prevalence of diabetes, impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care, 21, 518-524.
12.
Harris, M. I., Hadden, W. C., Knowler, W. C.,& Bennett, P. H. (1987). Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes, 36, 523-534.
13.
Herman, W. H., Smith, P. J., Thompson, T. J., Engelgau, M. M., & Aubert, R. E. (1997). A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care, 18, 382-387.
14.
Jack, N. H., Mbadugha, M. M., Mertz, K. J., Wu, M.,& Powell, K. E. (2003, June). Georgia diabetes report. Georgia Department of Human Resources, Division of Public Health, Chronic Disease Prevention and Health Promotion Branch (Publication No. DPH03-113HW).
15.
Knowler, W. C., Barrett-Connor, E., Fowler, S. E, Hermman, R. F., Lachin, J. M., Walker, E. A., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
16.
Knudson, P. E., Turner, K. J., Sedore, A.,& Weinstock, R. S. (1998). Utility of the American Diabetes Association risk test in a community screening program. Diabetes Care, 21, 1029-1030.
17.
Lindstrom, J.,& Tuomilehto, J. (2003). The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care, 26, 725-731.
18.
Martinez, N. (1993). Diabetes and minority populations. Diabetes, 28, 87-95.
19.
McGregor, M. S., Pinkham, C., Ahroni, J. H., Herter, C. D., & Doctor, J. D. (1995). The American Diabetes Association Risk Test for diabetes. Diabetes Care, 18, 585-586.
20.
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory(3rd ed.). New York: McGraw-Hill.
21.
Rolka, D. B., Narayan, K. M., Thompson, T. J., Goldman, D., Lindenmayer, J., & Alich, K. (2001). Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care, 24(11), 1899-1903.
22.
Ruige, J. B., de Neeling, J. N., Kostense, P. J., Bouter, L. M.,& Heine, R. J. (1997). Performance of an NIDDM screening questionnaire to identify people at increased risk for undiagnosed diabetes based on symptoms and risk factors. Diabetes Care, 20, 491-496.
23.
Tabael, B. P., Burke, R., Constance, A., Hare, J., May-Aldrich, G., Parker, S. A., et al. (2003). Community-based screening for diabetes in Michigan. Diabetes Care, 26, 668-670.
24.
Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T, Hamalainen, H., Ilanne-Parikka, P., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among participants with impaired glucose tolerance. New England Journal of Medicine, 344, 1343-1350.
25.
UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patient with type 2 diabetes (UKPDS33). The Lancet, 352, 837-853.
26.
Zhang, P., Engelgau, M. M., Valdez, R., Benjamin, S. M., Cadwell, B.,& Venkat Narayan, K. M. (2003). Costs of screening for pre-diabetes among U.S. adults: A comparison of different screening strategies. Diabetes Care, 26(9), 2536-2542.
